UiPath offers attractive AI automation exposure at a compelling valuation, with shares up ~35% YTD and strong Q3 results fueling momentum. PATH trades at 4.6x EV/FY27 revenue and 18.3x EV/FY27 FCF, ...

Revenue of $411 million increased 16 percent year-over-year ARR of $1.782 billion increased 11 percent year-over-year GAAP operating income of $13 million and non-GAAP operating income of $88 million ...

UiPath has expanded its India presence with a new 25,599 sq. ft. office in Bengaluru to accelerate its product development and R&D operations in the country. The company said the facility will serve ...

UiPath's consensus analyst price target has been modestly increased to $13.71 per share following the latest updates. This shift comes as experts weigh recent product announcements and revenue beats, ...

UiPath stock surged more than 40% this week following a new collaboration with ChatGPT maker OpenAI on agentic AI technology. The rally actually started last week when UiPath announced integrations ...

UiPath, Inc. (NYSE:PATH) released its second-quarter results after Thursday's closing bell. Here's a look at the details in the report. Check the status on PATH stock here. The Details: UiPath ...

UiPath Inc. investors can’t proceed with their proposed class action alleging the technology company misled them about sales and customer relationships as it implemented a turnaround strategy, a ...

Omega Healthcare partnered with UiPath to automate medical billing and other administrative tasks. The revenue cycle management company has saved employees hours with its AI document-processing tool.

UiPath stock rose Friday after the automation-software company’s earnings beat expectations and hiked guidance in its latest earnings report. The results eased fears that cuts in U.S. federal spending ...